MCI

NYSE Barings Corporate Investors
Oct 13, 2026 · 12:27 AM ET EOD Market Closed

$18.60 ↑ +0.00 (+0.00%) Trading Up from the previous close of $18.60, $0.12 below the day’s high of $18.72

YTD change
+2.48%
vs 20-day SMA
+0.77%
vs 200-day SMA
+1.05%

Price ranges

Previous day
$18.53 $18.74
open $18.63 close $18.67
+$0.04 (+0.21%)
Today
$18.54 $18.72
open $18.54 now $18.60
+$0.06 (+0.32%)
Past week
$17.51 $18.75
from $17.80 now $18.60
+$0.80 (+4.49%)
Past month
$17.49 $19.82
from $19.54 now $18.60
-$0.94 (-4.81%)
This year
$16.21 $21.17
from $18.15 now $18.60
+$0.45 (+2.48%)

Price & Performance

+1.00 (+5.68%) / 6M

$16.02$17.37$18.73$20.08Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 26.3% away from all-time highs of $25.24
  • MCI is up 2% since the beginning of the year
  • MCI is down 5% over the past 12 months
  • MCI is down 5% over the past 1 month

MCI reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -6.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Finance and Insurance
Sub Sector Funds, Trusts, and Other Financial Vehicles
Market cap $376.9M

Competitor comparison

TickerCompany PriceChange
DIA SPDR Dow Jones Industrial Average ETF $517.91 +0.35%
PGPHF Partners Group Holding AG $711.99 +0.99%
SEGXF SEGRO plc $12.30 +0.51%
CPAMF CapitaLand Integrated Commercial Trust $1.79 +4.68%
ARCC Ares Capital Corporation $18.63 +0.38%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.